3 posters presented
2023
Del Rosso, J., Kircik, L., Graber, E., Baldwin, H., Alexis, A. F., Fried, R. G., Harper, J. C., Hebert, A., Rieder, E., Stein Gold, L., Narayanan, S., Koscielny, V., & Kasujee, I. (2023) Reductions in severity of Acne Vulgaris among patients with moderate to severe non-nodular Acne Vulgaris administered sarecycline in community practices across the U.S in PROSES study: Analysis by concomitant medication use. Presented at Masterclasses in Dermatology 2023, February 23rd, 2023. Dallas, Texas.
Del Rosso, J., Schlesinger, T., Armstrong, A., Berman, B.,Bhatia, N., Kircik, L., Lebwohl, M., Patel, V., Rigel, Narayanan, S., Koscielny, V., and Kasujee, I. (2023) Clinician satisfaction with the use of tirbanibulin in the treatment of actinic keratosis (AK) in community practices across the U.S., and likelihood of prescribing tirbanibulin again for future treatment of AKs (PROAK study).Presented at Masterclasses in Dermatology 2023. February 23rd, 2023. Dallas, Texas.
Patel, V., Schlesinger, T., Armstrong, A., Berman, B.,Bhatia, Del Rosso, J., N., Kircik, L., Lebwohl, M., Rigel, Narayanan, S., Koscielny, V., and Kasujee, I. (2023) Patient satisfaction with tirbanibulin effectiveness, convenience of use, and overall satisfaction in community practices across the U.S., and patient likelihood to consider tirbanibulin again for future treatment of actinic keratosis (PROAK study) Presented at Masterclasses in Dermatology 2023. February 23rd, 2023. Dallas, Texas.
To request more information, send us an email at info@avant-health.com